Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering the role and contribution of AAV immune responses to DRG toxicity.

Molecular therapy. Advances·2026
Same author

AAVrh32.33 capsid demonstrates unexpected dermal tropism regardless of immunodominant epitope.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Kinetics of the O<sub>2</sub> Reactions with CH<sub>3</sub>OCO and CH<sub>2</sub>OCHO Formed from Methyl Formate.

The journal of physical chemistry. A·2026
Same author

SORT LNPs encapsulating Cas9 mRNA achieve efficient editing in skeletal muscle in a dystrophic mouse model.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Real-time direct detection of Criegee intermediates from ozonolysis of alkenes in an atmospheric simulation chamber.

Science advances·2026
Same author

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

The New England journal of medicine·2026

Related Experiment Video

Updated: May 16, 2026

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Advancing AAV technology-From promise to product

Juliette Hordeaux1, Allison M Keeler2, Daniel Stone3

  • 1Gemma Biotherapeutics, Inc., Philadelphia, PA, USA.

Molecular Therapy. Advances
|May 15, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

Suspension Culture Production and Purification of Adeno-Associated Virus by Iodixanol Density Gradient Centrifugation for In Vivo Applications
03:52

Suspension Culture Production and Purification of Adeno-Associated Virus by Iodixanol Density Gradient Centrifugation for In Vivo Applications

Published on: February 9, 2024

Related Experiment Videos

Last Updated: May 16, 2026

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

Suspension Culture Production and Purification of Adeno-Associated Virus by Iodixanol Density Gradient Centrifugation for In Vivo Applications
03:52

Suspension Culture Production and Purification of Adeno-Associated Virus by Iodixanol Density Gradient Centrifugation for In Vivo Applications

Published on: February 9, 2024